Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The effect of NNRTIs on HIV reverse transcriptase dimerization.

Gilda Tachedjian1, Stephen P Goff

  • 1Molecular Interactions Group, Macfarlane Burnet Institute for Medical Research and Public Health, Commercial Road, Melbourne, Victoria 3004, Australia.

Current Opinion in Investigational Drugs (London, England : 2000)
|September 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histone H1 promotes silencing of unintegrated HIV-1 DNA.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

HIV-1 infection induces Vif-mediated SUMOylation of host RNA splicing factors important for proper viral RNA splicing.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Characterisation of vaginal <i>Lactobacillus</i> isolates from South African women towards the development of a biotherapeutic to optimise the vaginal microbiome.

bioRxiv : the preprint server for biology·2026
Same author

Antiviral restriction factors of bats: the front line of a critical reservoir of zoonotic viruses.

Current opinion in virology·2026
Same author

Thermodynamic prediction of RNA cellular activity from sequence via conformational ensembles.

Cell·2026
Same author

Histone H1 Promotes Silencing of Unintegrated HIV-1 DNA.

bioRxiv : the preprint server for biology·2025
Same journal

Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?

Current opinion in investigational drugs (London, England : 2000)·2011
Same journal

Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.

Current opinion in investigational drugs (London, England : 2000)·2010
Same journal

Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.

Current opinion in investigational drugs (London, England : 2000)·2010
Same journal

Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.

Current opinion in investigational drugs (London, England : 2000)·2010
Same journal

Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.

Current opinion in investigational drugs (London, England : 2000)·2010
Same journal

Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.

Current opinion in investigational drugs (London, England : 2000)·2010
See all related articles

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) affect HIV-1 reverse transcriptase (RT) dimerization differently. Understanding these interactions could lead to more potent HIV-1 RT inhibitors.

Area of Science:

  • Biochemistry
  • Virology
  • Pharmacology

Background:

  • Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are crucial in HIV-1 treatment.
  • These drugs allosterically inhibit HIV-1 reverse transcriptase (RT).
  • NNRTIs are used in combination therapy for HIV-infected individuals.

Purpose of the Study:

  • To investigate the varying effects of NNRTIs on HIV-1 RT dimerization.
  • To explore the relationship between NNRTI binding modes and RT subunit interactions.
  • To identify potential new strategies for developing more effective HIV-1 RT inhibitors.

Main Methods:

  • Analysis of recent studies on NNRTI interactions with HIV-1 RT.
  • Comparison of the effects of conventional and unconventional NNRTIs on RT dimerization.

Related Experiment Videos

  • Evaluation of the impact of subunit interaction modulation on enzyme function.

    • Main Results:

    • Different NNRTIs exhibit varied effects on HIV-1 RT dimerization, including enhancement and destabilization.
    • Conventional NNRTIs like efavirenz strongly enhance RT dimerization.
    • Unconventional NNRTIs destabilize the RT subunit, potentially interfering with essential conformational changes.

    Conclusions:

    • Modulation of subunit interaction by NNRTIs is a key property of these HIV-1 RT inhibitors.
    • This property offers a novel target for designing more potent anti-HIV drugs.
    • Exploiting NNRTI-induced changes in RT dimerization could enhance HIV treatment efficacy.